These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

128 related articles for article (PubMed ID: 28592157)

  • 1. Correlation Between Nasal Epithelial Injury and In Vitro Cytotoxicity Using a Series of Small Molecule Protein Tyrosine Phosphatase 1B Inhibitors Investigated for Reversal of Leptin Resistance in Obesity.
    Brown AP; Saravanan C; Devine P; Magnifico M; Gao J; Beaulieu V; Ma F; Yasoshima K; Barnes-Seeman D; Yamada K
    Int J Toxicol; 2017; 36(4):303-313. PubMed ID: 28592157
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Therapeutic effects of the allosteric protein tyrosine phosphatase 1B inhibitor KY-226 on experimental diabetes and obesity via enhancements in insulin and leptin signaling in mice.
    Ito Y; Fukui M; Kanda M; Morishita K; Shoji Y; Kitao T; Hinoi E; Shirahase H
    J Pharmacol Sci; 2018 May; 137(1):38-46. PubMed ID: 29731242
    [TBL] [Abstract][Full Text] [Related]  

  • 3. 3-Phenylpropanoic acid-based phosphotyrosine (pTyr) mimetics: hit evolution to a novel orally active protein tyrosine phosphatase 1B (PTP1B) inhibitor.
    Tang YB; Liu JZ; Zhang SE; Du X; Nie F; Tian JY; Ye F; Huang K; Hu JP; Li Y; Xiao Z
    ChemMedChem; 2014 May; 9(5):918-21. PubMed ID: 24644278
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Discovery of Bisindole as a Novel Scaffold for Protein Tyrosine Phosphatase 1B Inhibitors.
    Jing C; Li Z; Jia K; Chen C; Liu X; Wang B; Hu W; Li J; Zhu T; Dong S
    Arch Pharm (Weinheim); 2017 Jan; 350(1):. PubMed ID: 28029177
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A novel protein tyrosine phosphatase 1B inhibitor with therapeutic potential for insulin resistance.
    Zhang X; Tian J; Li J; Huang L; Wu S; Liang W; Zhong L; Ye J; Ye F
    Br J Pharmacol; 2016 Jun; 173(12):1939-49. PubMed ID: 26990621
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Recent Advances in Protein Tyrosine Phosphatase 1B Targeted Drug Discovery for Type II Diabetes and Obesity.
    Maheshwari N; Karthikeyan C; Trivedi P; Moorthy NSHN
    Curr Drug Targets; 2018; 19(5):551-575. PubMed ID: 28228082
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Protein tyrosine phosphatase 1B (PTP1B) and obesity.
    Cho H
    Vitam Horm; 2013; 91():405-24. PubMed ID: 23374726
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Novel protein tyrosine phosphatase 1B inhibitors: interaction requirements for improved intracellular efficacy in type 2 diabetes mellitus and obesity control.
    Popov D
    Biochem Biophys Res Commun; 2011 Jul; 410(3):377-81. PubMed ID: 21683066
    [TBL] [Abstract][Full Text] [Related]  

  • 9. 7-Phenyl-pyrido[2,3-d]pyrimidine-2,4-diamines: novel and highly selective protein tyrosine phosphatase 1B inhibitors.
    Cheung AW; Banner B; Bose J; Kim K; Li S; Marcopulos N; Orzechowski L; Sergi JA; Thakkar KC; Wang BB; Yun W; Zwingelstein C; Berthel S; Olivier AR
    Bioorg Med Chem Lett; 2012 Dec; 22(24):7518-22. PubMed ID: 23122867
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Complement-mediated glomerular injury is reduced by inhibition of protein-tyrosine phosphatase 1B.
    Nezvitsky L; Tremblay ML; Takano T; Papillon J; Cybulsky AV
    Am J Physiol Renal Physiol; 2014 Sep; 307(5):F634-47. PubMed ID: 25056348
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Intranasal Targeting of Hypothalamic PTP1B and TCPTP Reinstates Leptin and Insulin Sensitivity and Promotes Weight Loss in Obesity.
    Dodd GT; Xirouchaki CE; Eramo M; Mitchell CA; Andrews ZB; Henry BA; Cowley MA; Tiganis T
    Cell Rep; 2019 Sep; 28(11):2905-2922.e5. PubMed ID: 31509751
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Functional properties of Claramine: a novel PTP1B inhibitor and insulin-mimetic compound.
    Qin Z; Pandey NR; Zhou X; Stewart CA; Hari A; Huang H; Stewart AF; Brunel JM; Chen HH
    Biochem Biophys Res Commun; 2015 Feb; 458(1):21-7. PubMed ID: 25623533
    [TBL] [Abstract][Full Text] [Related]  

  • 13. In silico structure-based design of a potent and selective small peptide inhibitor of protein tyrosine phosphatase 1B, a novel therapeutic target for obesity and type 2 diabetes mellitus: a computer modeling approach.
    Rao GS; Ramachandran MV; Bajaj JS
    J Biomol Struct Dyn; 2006 Feb; 23(4):377-84. PubMed ID: 16363874
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Design, synthesis and biological evaluation of uncharged catechol derivatives as selective inhibitors of PTP1B.
    Li XQ; Xu Q; Luo J; Wang LJ; Jiang B; Zhang RS; Shi DY
    Eur J Med Chem; 2017 Aug; 136():348-359. PubMed ID: 28511130
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Design, synthesis, and biological evaluation of novel 2-ethyl-5-phenylthiazole-4-carboxamide derivatives as protein tyrosine phosphatase 1B inhibitors with improved cellular efficacy.
    Chen YT; Tang CL; Ma WP; Gao LX; Wei Y; Zhang W; Li JY; Li J; Nan FJ
    Eur J Med Chem; 2013 Nov; 69():399-412. PubMed ID: 24090912
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Discovery of novel, high potent, ABC type PTP1B inhibitors with TCPTP selectivity and cellular activity.
    Liu P; Du Y; Song L; Shen J; Li Q
    Eur J Med Chem; 2016 Aug; 118():27-33. PubMed ID: 27123900
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Novel Non-carboxylate Benzoylsulfonamide-Based Protein Tyrosine Phosphatase 1B Inhibitors with Non-competitive Actions.
    Morishita K; Shoji Y; Tanaka S; Fukui M; Ito Y; Kitao T; Ozawa SI; Hirono S; Shirahase H
    Chem Pharm Bull (Tokyo); 2017; 65(12):1144-1160. PubMed ID: 29199219
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Role of protein tyrosine phosphatase 1B in the type 2 diabetes and obesity].
    Wang C; Wang L; Yang Z
    Yi Chuan; 2004 Nov; 26(6):941-6. PubMed ID: 15640130
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Protein tyrosine phosphatase-1B contributes to LPS-induced leptin resistance in male rats.
    Borges Bde C; Rorato RC; Uchoa ET; Marangon PB; Elias CF; Antunes-Rodrigues J; Elias LL
    Am J Physiol Endocrinol Metab; 2015 Jan; 308(1):E40-50. PubMed ID: 25352433
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Trivaric acid, a new inhibitor of PTP1b with potent beneficial effect on diabetes.
    Sun W; Zhang B; Zheng H; Zhuang C; Li X; Lu X; Quan C; Dong Y; Zheng Z; Xiu Z
    Life Sci; 2017 Jan; 169():52-64. PubMed ID: 27871946
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.